Novel immune checkpoint inhibitor strategies in advanced non-small cell lung cancer: towards biomarker-driven therapies?

Benthe B. Muntinghe-Wagenaar; T. Jeroen N. Hiltermann

doi:10.21037/tlcr-24-966

Novel immune checkpoint inhibitor strategies in advanced non-small cell lung cancer: towards biomarker-driven therapies?

Benthe B. Muntinghe-Wagenaar, T. Jeroen N. Hiltermann^*

^*Corresponding author for this work

Translational Immunology Groningen (TRIGR)

Research output: Contribution to journal › Editorial › Academic › peer-review

37 Downloads (Pure)

Original language	English
Pages (from-to)	328-333
Number of pages	6
Journal	Translational lung cancer research
Volume	14
Issue number	2
DOIs	https://doi.org/10.21037/tlcr-24-966
Publication status	Published - 28-Feb-2025

Keywords

biomarker
Immune checkpoint inhibition
non-small cell lung cancer (NSCLC)
programmed death-ligand 1 (PD-L1)

Access to Document

10.21037/tlcr-24-966Licence: CC BY-NC-ND

Novel immune checkpoint inhibitor strategies in advanced non-small cell lung cancerFinal publisher's version, 195 KBLicence: CC BY-NC-ND

Handle.net

Persistent link

Cite this

@article{bd004fad510241c98ccad25ff6485602,

title = "Novel immune checkpoint inhibitor strategies in advanced non-small cell lung cancer: towards biomarker-driven therapies?",

keywords = "biomarker, Immune checkpoint inhibition, non-small cell lung cancer (NSCLC), programmed death-ligand 1 (PD-L1)",

author = "Muntinghe-Wagenaar, {Benthe B.} and Hiltermann, {T. Jeroen N.}",

year = "2025",

month = feb,

day = "28",

doi = "10.21037/tlcr-24-966",

language = "English",

volume = "14",

pages = "328--333",

journal = "Translational lung cancer research",

issn = "2218-6751",

publisher = "AME PUBL CO",

number = "2",

}

TY - JOUR

T1 - Novel immune checkpoint inhibitor strategies in advanced non-small cell lung cancer

T2 - towards biomarker-driven therapies?

AU - Muntinghe-Wagenaar, Benthe B.

AU - Hiltermann, T. Jeroen N.

PY - 2025/2/28

Y1 - 2025/2/28

KW - biomarker

KW - Immune checkpoint inhibition

KW - non-small cell lung cancer (NSCLC)

KW - programmed death-ligand 1 (PD-L1)

UR - http://www.scopus.com/inward/record.url?scp=85219580293&partnerID=8YFLogxK

U2 - 10.21037/tlcr-24-966

DO - 10.21037/tlcr-24-966

M3 - Editorial

AN - SCOPUS:85219580293

SN - 2218-6751

VL - 14

SP - 328

EP - 333

JO - Translational lung cancer research

JF - Translational lung cancer research

IS - 2

ER -

Novel immune checkpoint inhibitor strategies in advanced non-small cell lung cancer: towards biomarker-driven therapies?

Keywords

Access to Document

Handle.net

Other files and links

TLCR Outstanding Author interview

TLCR Outstanding Author

Cite this

Novel immune checkpoint inhibitor strategies in advanced non-small cell lung cancer: towards biomarker-driven therapies?

Keywords

Access to Document

Handle.net

Other files and links

Press/Media

TLCR Outstanding Author interview

Prizes

TLCR Outstanding Author

Cite this